Document is current
Any future updates will be listed below
-
Authors
Straughn, Arthur B. https://orcid.org/0009-0006-3388-5636
Silva, Raul
Cattaneo, Michael J. https://orcid.org/0000-0001-6097-362X
Koehn, Kelly https://orcid.org/0000-0003-3484-1636
Brams, Matthew https://orcid.org/0000-0002-7926-6113
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04138498 at ClinicalTrials.govDocuments that mention this clinical trial
Comparative Bioavailability of Trimodal (CTx-1301) Versus Bimodal Dexmethylphenidate Modified-Release Formulations in Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Single-Dose, Crossover Study
https://doi.org/10.1007/s40263-026-01319-3
-
Funding
Funding for this research was provided by:
Cingulate Therapeutics
- License Information
-
More Information
Article History
Received: 2 February 2026
Accepted: 22 June 2026
First Online: 28 July 2026
Declarations
Conflict of interest: A.B.S. is a co-founder, consultant, and shareholder of Cingulate Therapeutics; R.S., M.J.C., K.K., and M.B. are employed by and are shareholders in Cingulate Therapeutics.
Ethics approval: The study was approved by an institutional review board and was conducted in accordance with the principles of the Declaration of Helsinki, ICH-GCP and GLP guidelines, and applicable regulatory requirements.
Consent to participate: All participants provided written informed consent before initiating any study-specific procedures.
Consent to publication: Not applicable.
Availability of data and material: Participant-level, de-identified clinical data and data dictionary pertaining to this study may be shared with other researchers with publication. Emails can be sent to medicalaffairs@cingulate.com for details regarding data availability, instructions for requesting information, and sharing agreements. Data will be shared only after approval of proposal.
Code availability: Not applicable.
Author contributions: All authors contributed to the conception and design of the work and/or the acquisition, analysis, or interpretation of the data; were involved in critically reviewing and revising manuscript drafts; approved the final version of the manuscript; and agreed to be accountable for all aspects of the work.
